Condition: Atrioventricular Block, Second and Third Degree · Sponsor: Medical University of Silesia
The study aims to compare permanent Conduction System Pacing (CSP) with the standard therapy - Right Ventricular Pacing (RVP) or Biventricular Pacing (BVP) - in preventing the development and progression of symptomatic Chronic Heart Failure (CHF) and improving survival in patients after Transcatheter Aortic Valve Implantation (TAVI).
This description comes directly from the study's public registry record.
Krzysztof S. Gołba, MD PhD · +48 (32)359-88-93 · krzysztof.golba@gmail.com
Tomasz Soral, MD · tomasz.soral@gmail.com
Always discuss trial participation with your own doctor first.
| Medical University of Silesia in Katowice | Katowice, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05966675